Lamotrigine 25-50-100mg 30 tablets

Composition
active substance: lamotrigine;

1 tablet contains lamotrigine 100 mg;

excipients: microcrystalline cellulose, colloidal anhydrous silicon dioxide, povidone, sodium starch glycolate (type A), lactose monohydrate, magnesium stearate.

Pharmacotherapeutic group
Antiepileptic drugs. Lamotrigine. ATX code N03A X09.

Indication
Epilepsy.

Adults and children over 13 years of age: monotherapy and adjunctive therapy for partial and generalized seizures, including tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome. The drug Lamotrine is prescribed as an adjunctive therapy, but in Lennox-Gastaut syndrome it can be prescribed as an initial antiepileptic drug (AED).

Children aged 2 to 12 years: adjunctive therapy for epilepsy, including partial and generalized seizures, including tonic-clonic seizures, as well as seizures associated with Lennox-Gastaut syndrome.

Monotherapy of typical absences.

Bipolar disorders in adults.

Adults (age 18 and over).

To prevent depressive states in patients with bipolar I disorder, who mainly suffer from depressive states.

Lamotrigine is not indicated for the acute treatment of manic or depressive episodes.